{
    "code": "06008836",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06008836",
    "time": "2020-03-13 03:27:59",
    "許可證字號": "衛署醫器輸字第008836號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD1073",
    "有效日期": "112\/09\/14",
    "發證日期": "87\/09\/14",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA00600883601",
    "中文品名": "&quot;愛爾康比利時廠&quot;多微視組合玻璃體替代物",
    "英文品名": "DUOVISC-VISCOELASTIC SYSTEM",
    "效能": "眼科手術玻璃體替代物",
    "醫器規格": "ＰＲＯＶＩＳＣ　０．４公撮注射針筒裝＋ＶＩＳＣＯＡＴ　０．３５公撮注射針筒裝\r\n規格變更：\r\n1. Provisc之賦形劑變更：原Disodium Phosphate, anhydrous 0.56 mg\/ml變更為2.0 mg\/ml；原Sodium Dihydrogen Phosphate, monohydrate 0.04 mg\/ml變更為0.45 mg\/ml；原Sodium Chloride 8.4 mg\/ml變更為7.5 mg\/ml。\r\n2. Provisc之包裝容器變更。\r\n3. Provisc之玻尿酸鈉原料供應商變更。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "0314人工水晶體眼球",
    "醫器次類別一": "",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "1304601100  瑞士商愛爾康大藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區仁愛路二段99號11樓",
    "主製造廠": [
        {
            "製造廠名稱": "MBE0009000  S.A. ALCON COUVREUR N.V.",
            "製造廠廠址": "RIJSWEG, 14 2870 PUURS BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "201306040922仿單-102-06-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06008836&Seq=001&Type=9"
        },
        {
            "title": "201306040922標籤-102-06-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06008836&Seq=001&Type=8"
        }
    ]
}